Free Trial

CEL-SCI (CVM) Insider Trading & Ownership

CEL-SCI logo
$0.73 -0.04 (-4.60%)
(As of 12/20/2024 05:40 PM ET)

CEL-SCI (NYSE:CVM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.24%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$80,620.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get CVM Insider Trade Alerts

Want to know when executives and insiders are buying or selling CEL-SCI stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CVM Insider Buying and Selling by Quarter

CEL-SCI Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/8/2024Geert R KerstenCEOBuy30,000$1.39$41,700.00  
5/8/2024Patricia B PrichepSVPBuy8,000$1.39$11,120.00  
5/8/2024Robert Eugene WatsonDirectorBuy20,000$1.39$27,800.00  
(Data available from 1/1/2013 forward)

CVM Insider Trading Activity - Frequently Asked Questions

The list of insiders at CEL-SCI includes Geert R Kersten, Patricia B Prichep, and Robert Eugene Watson. Learn more on insiders at CVM.

16.24% of CEL-SCI stock is owned by insiders. Learn more on CVM's insider holdings.

The following insiders have purchased CVM shares in the last 24 months: Geert R Kersten ($41,700.00), Patricia B Prichep ($11,120.00), and Robert Eugene Watson ($27,800.00).

Insiders have purchased a total of 58,000 CVM shares in the last 24 months for a total of $80,620.00 bought.

CEL-SCI Key Executives

  • Mr. Geert R. Kersten Esq. (Age 65)
    Chief Executive & Financial Officer, Treasurer and Director
    Compensation: $702.79k
  • Ms. Patricia B. Prichep (Age 73)
    Senior VP of Operations & Corporate Secretary
    Compensation: $295.18k
  • Dr. Eyal Talor Ph.D. (Age 68)
    Chief Scientific Officer
    Compensation: $351.88k
  • Dr. Daniel H. Zimmerman Ph.D. (Age 83)
    Senior Vice President of Research & Cellular Immunology
    Compensation: $46.08k
  • Mr. John Cipriano (Age 82)
    Senior Vice President of Regulatory Affairs
    Compensation: $246.97k


This page (NYSE:CVM) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners